AVTX logo

Avalo Therapeutics, Inc. (AVTX)

Profile

Full Name

Avalo Therapeutics, Inc.

Ticker

NASDAQ: AVTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 14, 2015

Indexes

Not included

Website

https://www.avalotx.com

Employees

23

Key Details

Price

$7.89(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$441.00K(-77.08% YoY)

Annual EPS

-$20.91(+81.59% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.89
    AVTX price is $7.89

    30-Day Relative Volume

    1.71
    AVTX 30-day relative volume is 1.71

    Price Performance

    Price Most recent change

    0%
    AVTX price has remained unchanged on Aug 1, 2025

    Price YTD change

    +6.19%
    AVTX price is up +6.19% since January 1st

    Price 1-year change

    -28.6%
    AVTX price is down -28.6% year-on-year

    Price 3-year change

    -99.09%
    AVTX price is down -99.09% over the past 3 years

    Price Range

    Price All-time high

    $22.03K
    AVTX price is currently -99.96% below its historical high of $22.03 thousand

    Price 3-year low

    $3.39
    AVTX price is currently +132.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $85.43M
    AVTX market capitalization is $85.43 million

    Market cap 3-year change

    +152.24%
    AVTX market capitalization is up +152.24% over the past 3 years

    Market cap All-time high

    $59.70B
    AVTX market capitalization is currently -99.86% below its historical high of $59.70 billion

    Market cap sector rank

    41.7%
    AVTX market capitalization is higher than 41.7% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +947.06%
    AVTX shares outstanding is up +947.06% year-on-year

    Shares Outstanding 3-Year Change

    +27521.43%
    AVTX shares outstanding is up +27521.43% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.52
    AVTX beta is 0.52

    200-day SMA

    $7.38
    AVTX price is currently +6.89% above its 200-day simple moving average

    50-day SMA

    $5.07
    AVTX price is currently +55.69% above its 50-day simple moving average

    RSI

    80.63
    AVTX 14-day relative strength index is 80.63

    Volume

    1.71
    AVTX 30-day relative volume is 1.71

    ATR

    $0.60
    AVTX average true range is $0.60

    10-day Historical Volatility

    103.15%
    AVTX 10-day historical volatility is 103.15%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $441.00K
    AVTX annual revenue is $441.00 thousand

    Revenue Analysts estimate

    -
    AVTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -77.08%
    AVTX annual revenue is down -77.08% year-on-year

    Revenue Sector rank

    8.7%
    AVTX annual revenue is higher than 8.7% of companies in Healthcare sector

    EPS

    EPS

    -$20.91
    AVTX annual earnings per share is -$20.91

    EPS Analysts estimate

    -$5.34
    AVTX annual earnings per share is currently +291.33% higher than the consensus analysts' forecast

    EPS 1-year change

    +81.59%
    AVTX annual earnings per share is up +81.59% year-on-year

    EPS Sector rank

    7.65%
    AVTX annual earnings per share is higher than 7.65% of companies in Healthcare sector

    Profit

    Gross profit

    $807.00K
    AVTX annual gross profit is $807.00 thousand

    Gross margin

    182.99%
    AVTX annual gross profit margin is 182.99%

    Operating profit

    -$40.87M
    AVTX annual operating income is -$40.87 million

    Operating margin

    -15.54K%
    AVTX annual operating profit margin is -15.54 thousand%

    Net income

    -$35.13M
    AVTX annual net profit is -$35.13 million

    Net margin

    -7965.76%
    AVTX annual net profit margin is -7965.76%

    Expenses

    Total expenses

    $41.31M
    AVTX annual total expenses is $41.31 million

    Operating expenses

    $41.68M
    AVTX annual total operating expenses is $41.68 million

    Cost of goods sold

    -$366.00K
    AVTX annual cost of goods sold is -$366.00 thousand

    Selling, general & administrative expenses

    $17.24M
    AVTX annual SGA is $17.24 million

    Depreciation and amortization

    $169.00K
    AVTX annual depreciation & amortization is $169.00 thousand

    Interest expense

    -$3.32M
    AVTX annual interest expense is -$3.32 million

    Income tax

    $114.00K
    AVTX annual income tax is $114.00 thousand

    EBIT & EBITDA

    EBIT

    -$38.33M
    AVTX annual earnings before interest & taxes is -$38.33 million

    EBITDA

    -$38.16M
    AVTX annual EBITDA is -$38.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $150.73M
    AVTX annual total assets is $150.73 million

    Non current assets

    $11.84M
    AVTX annual long term assets is $11.84 million

    Current assets

    $138.89M
    AVTX annual total current assets is $138.89 million

    Cash and cash equivalents

    $134.55M
    AVTX annual cash & cash equivalents is $134.55 million

    Accounts receivable

    -
    AVTX annual accounts receivable value is unknown

    Inventory

    -
    AVTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $17.70M
    AVTX annual total liabilities is $17.70 million

    Long term liabilities

    $10.74M
    AVTX annual total long term liabilities is $10.74 million

    Current liabilities

    $6.96M
    AVTX annual total current liabilities is $6.96 million

    Accounts payable

    $283.00K
    AVTX annual accounts payable is $283.00 thousand

    Debt

    Total debt

    $568.00K
    AVTX annual total debt is $568.00 thousand

    Total debt 1-year change

    +5.77%
    AVTX annual total debt is up +5.77% year-on-year

    Long term debt

    -
    AVTX annual long term debt value is unknown

    Short term debt

    $568.00K
    AVTX annual short term debt is $568.00 thousand

    Equity & Capital

    Shareholders equity

    $133.03M
    AVTX annual stockholders equity is $133.03 million

    Book value

    $133.03M
    AVTX annual book value is $133.03 million

    Retained earnings

    -$370.26M
    AVTX annual retained earnings is -$370.26 million

    Working capital

    $131.93M
    AVTX annual working capital is $131.93 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$49.06M
    AVTX annual cash flow from operations is -$49.06 million

    Cash from operations 1-year change

    -59.9%
    AVTX annual cash flow from operations is down -59.9% year-on-year

    Cash from investing

    $356.00K
    AVTX annual cash flow from investing activities is $356.00 thousand

    Cash from investing 1-year change

    +367.67%
    AVTX annual cash flow from investing activities is up +367.67% year-on-year

    Cash from financing

    $175.85M
    AVTX annual cash flow from financing activities is $175.85 million

    Cash from financing 1-year change

    +602.22%
    AVTX annual cash flow from financing activities is up +602.22% year-on-year

    CAPEX

    CAPEX

    -
    AVTX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AVTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$49.06M
    AVTX annual free cash flow is -$49.06 million

    Free cash flow 1-year change

    -59.9%
    AVTX annual free cash flow is down -59.9% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    182.99%
    AVTX annual gross profit margin is 182.99%

    Operating margin

    -15.54K%
    AVTX annual operating profit margin is -15.54 thousand%

    Net margin

    -7965.76%
    AVTX annual net profit margin is -7965.76%

    ROA & ROE

    ROA

    -40.91%
    AVTX annual return on assets is -40.91%

    ROE

    -50.06%
    AVTX annual return on equity is -50.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AVTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AVTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.70
    AVTX price to book ratio is 0.70

    PB ratio Sector rank

    31.78%
    AVTX price to book ratio is higher than 31.78% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AVTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AVTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$38.82M
    AVTX enterprise value is -$38.82 million

    Enterprise value Sector rank

    1.51%
    AVTX enterprise value is higher than 1.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.77
    AVTX EV/EBITDA is 0.77

    EV/EBITDA Sector rank

    74.71%
    AVTX EV/EBITDA is higher than 74.71% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    19.96
    AVTX annual current ratio is 19.96

    Quick ratio

    -
    AVTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    AVTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    11.56
    AVTX annual interest coverage ratio is 11.56

    Risk & Stability

    Piotroski F-Score

    -
    AVTX piotroski f-score value is unknown

    Altman Z-Score

    -0.33
    AVTX altman z-score is -0.33

    Analyst ratings

    Recent major analysts updates

    Mar 25, 25 Stifel
    Buy
    Mar 25, 25 Jefferies
    Buy
    Mar 20, 25 HC Wainwright & Co.
    Neutral
    Feb 28, 25 Piper Sandler
    Overweight
    Dec 19, 24 BTIG
    Buy
    Dec 17, 24 LUCID CAPITAL MARKETS
    Buy
    Oct 24, 24 HC Wainwright & Co.
    Neutral
    Apr 16, 24 Oppenheimer
    Outperform
    Jun 27, 23 RBC Capital
    Sector Perform
    Jun 27, 23 Oppenheimer
    Perform

    Institutional Ownership

    Screeners with AVTX included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Avalo Therapeutics, Inc.?
    • Does Avalo Therapeutics, Inc. pay dividends?
    • What sector is Avalo Therapeutics, Inc. in?
    • What industry is Avalo Therapeutics, Inc. in?
    • What country is Avalo Therapeutics, Inc. based in?
    • When did Avalo Therapeutics, Inc. go public?
    • Is Avalo Therapeutics, Inc. in the S&P 500?
    • Is Avalo Therapeutics, Inc. in the NASDAQ 100?
    • Is Avalo Therapeutics, Inc. in the Dow Jones?
    • When was Avalo Therapeutics, Inc.'s last earnings report?
    • When does Avalo Therapeutics, Inc. report earnings?

    What is the ticker symbol for Avalo Therapeutics, Inc.?

    The ticker symbol for Avalo Therapeutics, Inc. is NASDAQ:AVTX

    Does Avalo Therapeutics, Inc. pay dividends?

    No, Avalo Therapeutics, Inc. does not pay dividends

    What sector is Avalo Therapeutics, Inc. in?

    Avalo Therapeutics, Inc. is in the Healthcare sector

    What industry is Avalo Therapeutics, Inc. in?

    Avalo Therapeutics, Inc. is in the Biotechnology industry

    What country is Avalo Therapeutics, Inc. based in?

    Avalo Therapeutics, Inc. is headquartered in United States

    When did Avalo Therapeutics, Inc. go public?

    Avalo Therapeutics, Inc.'s initial public offering (IPO) was on October 14, 2015

    Is Avalo Therapeutics, Inc. in the S&P 500?

    No, Avalo Therapeutics, Inc. is not included in the S&P 500 index

    Is Avalo Therapeutics, Inc. in the NASDAQ 100?

    No, Avalo Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Avalo Therapeutics, Inc. in the Dow Jones?

    No, Avalo Therapeutics, Inc. is not included in the Dow Jones index

    When was Avalo Therapeutics, Inc.'s last earnings report?

    Avalo Therapeutics, Inc.'s most recent earnings report was on May 12, 2025

    When does Avalo Therapeutics, Inc. report earnings?

    The next expected earnings date for Avalo Therapeutics, Inc. is August 12, 2025
    On this page